Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study

Abstract Background An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of symptomatic compared to asymptomatic patients with PE or DVT. Methods This...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Tsutomu Yamazaki, Atsushi Hirayama, on behalf of the J’xactly Investigators
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-08-01
Series:	Thrombosis Journal
Assuntos:	Anticoagulant Bleeding Recurrence Rivaroxaban Venous thromboembolism
Acceso en liña:	https://doi.org/10.1186/s12959-023-00528-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!